Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.82 -0.08 (-8.89%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alaunos Therapeutics (TCRT) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Alaunos Therapeutics (TCRT) posted Depreciation & Amortization (CF) of $9,000 for Q2 2026, up 12.5% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Alaunos Therapeutics was $24,000; for FY2025, it was $7,000, up 250.0% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -63.8% (FY2020 to FY2025).
  • In prior years, Alaunos Therapeutics' Depreciation & Amortization (CF) was $2,000 in FY2024 (-99.9%), $2.32 million in FY2023 (-17.3%), $2.8 million in FY2022 (+7.7%) and $2.6 million in FY2021 (+130.5%).
  • The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) since Q4 2023.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2021, with growth of 111.6%; the weakest was Q2 2024, with a decline of 99.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 Alaunos Therapeutics 2.04 Mn -1.76 Mn - 9,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9,000.00
Mar 31, 2026 8,000.00
Dec 31, 2025 7,000.00
Dec 31, 2024 -1,000.00
Jun 30, 2024 1,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 241,000.00
Sep 30, 2023 679,000.00
Jun 30, 2023 699,000.00
Mar 31, 2023 696,000.00
Dec 31, 2022 735,000.00
Sep 30, 2022 691,000.00
Jun 30, 2022 685,000.00
Mar 31, 2022 689,000.00
Dec 31, 2021 708,000.00
Sep 30, 2021 673,000.00
Jun 30, 2021 679,000.00
Mar 31, 2021 540,000.00
Dec 31, 2020 420,000.00
Sep 30, 2020 318,000.00
API Access

Alaunos Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TCRT&period=max&api_key=YOUR_API_KEY